GSK Plc (GSK)
57.13
-0.68
(-1.18%)
USD |
NYSE |
Apr 16, 16:00
57.35
+0.22
(+0.39%)
Pre-Market: 08:29
GSK Research and Development Expense (Quarterly) : 3.112B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.725B |
| Biodexa Pharmaceuticals Plc | -- |
| Novavax, Inc. | 73.98M |
| BioNTech SE | 588.25M |
| Moderna, Inc. | 708.00M |